Literature DB >> 34971898

Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions.

Mohammed E Choudhury1, Kanta Mikami2, Yuiko Nakanishi2, Taisei Matsuura2, Ryo Utsunomiya2, Hajime Yano2, Madoka Kubo3, Rina Ando3, Jun Iwanami4, Masakatsu Yamashita5, Masahiro Nagai3, Junya Tanaka2.   

Abstract

Myeloid differentiation primary response gene 88 (MyD88) is essential for microglial activation. Despite the significant role of microglia in regulating sleep homeostasis, the contribution of MyD88 to sleep is yet to be determined. To address this, we performed electroencephalographic and electromyographic recordings on MyD88-KO mice and wild-type mice to investigate their sleep/wake cycles. In the daytime, MyD88-KO mice exhibited prolonged wakefulness and shorter non-rapid eye movement sleep duration. Tail suspension and sucrose preference tests revealed that MyD88-KO mice displayed a depressive-like phenotype. We determined monoamines in the prefrontal cortex (PFC) using high-performance liquid chromatography and observed a decreased content of serotonin in the PFC of MyD88-KO mice. Flow cytometry revealed that CD11b, CD45, and F4/80 expressions were elevated at Zeitgeber time (ZT) 1 compared to at ZT13 only in wild-type mice. Furthermore, MFG-E8 and C1qB-tagged synapses were enhanced at ZT1 in the PFC of wild-type mice but not in MyD88-KO mice. Primary cultured microglia from MyD88-KO mice revealed decreased phagocytic ability. These findings indicate that genetic deletion of MyD88 induces insomnia and depressive behavior, at least in part, by affecting microglial homeostasis functions and lowering the serotonergic neuronal output.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flow cytometry; Microglia; MyD88; Phagocytosis; Sleep; Synapse

Mesh:

Substances:

Year:  2021        PMID: 34971898     DOI: 10.1016/j.jneuroim.2021.577794

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  1 in total

1.  Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson's Disease Models.

Authors:  Satoshi Tada; Mohammed E Choudhury; Madoka Kubo; Rina Ando; Junya Tanaka; Masahiro Nagai
Journal:  Brain Sci       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.